Company intelligence / Profile preview

Cyclotek

Bundoora, Victoria, Australia

Ownership: Private
Employees: ~73
Development stage: Other

Overview

Cyclotek has a robust commercial operation producing and supplying eleven clinical and research PET radiopharmaceuticals; the company supports clinical trials and investigator-sponsored studies, but specific clinical outcome data are not disclosed.

Therapeutic areas: OncologyNeurology
Modalities: RadiopharmaceuticalDiagnostic agentTherapeutic agent
Industry: Biotech

Partnerships

Pacific Radiology Group (joint venture, Wellington, NZ)University of Melbourne (radiopharmaceutical R&D centre)Multiple undisclosed pharma, biotech CDMO partners

Beyond the preview

Go deeper on Cyclotek.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclotek.

Explore the full profile